Emgality is a prescription medicine used for the preventive treatment of migraine in adults. Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality. Emgality can help give you more migraine-free days. Emgality cut the number of monthly migraine days by 50% or more for some patients.

Find Emgality® support resources, including information about the savings card for eligible patients, LillyDirect™ Pharmacy Solutions, and independent virtual and in-person care.

Discover what Emgality® can do and see if it's right for you. Find information about the efficacy of Emgality for the preventive treatment of migraine in adults.

Emgality (Galcanezumab-gnlm) injection 120mg/mL for the prevention treatment for migraines in adults.

EMGALITY® (em-GAL-it-ē) (galcanezumab-gnlm) injection, for subcutaneous use What is EMGALITY? • preventive treatment of migraine. • treatment of episodic cluster headache. It is not known if EMGALITY is safe and effective in children. Who should not use EMGALITY?

EMGALITY is indicated for the treatment of episodic cluster headache in adults. The recommended dosage of EMGALITY is 240 mg (two consecutive subcutaneous injections of 120 mg each) once as a loading dose, followed by monthly doses of 120 mg injected subcutaneously. If a dose of EMGALITY is missed, administer as soon as possible.

Sep 5, 2024 · Emgality is a prescription medicine used to prevent migraines and treat episodic cluster headaches in adults. Emgality can help reduce the number of migraine days per month and reduce the number of cluster headache attacks each week. Emgality is calcitonin-gene related peptide antagonist.

Jun 20, 2023 · When the Biohaven-owned oral migraine drug Nurtec ODT started steaming ahead in 2021, Eli Lilly sought to blunt the rival’s momentum with a trial designed to show its injectable Emgality...

The recommended dose of Emgality (galcanezumab) for migraine prevention is 120 mg injected subcutaneously once monthly, with a 240-mg loading dose as the initial dose.

2.3 Important Administration Instructions EMGALITY is for subcutaneous use only. EMGALITY is intended for patient self-administration. Prior to use, provide proper training to patients and/or caregivers on how to prepare and administer EMGALITY using the single-dose prefilled pen or single-dose prefilled syringe, including aseptic technique [see How Supplied/Storage and Handling and ...